During the past decade, Kocaeli University Medical Faculty conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 23 clinical trials were completed, i.e. on average, 31.1% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 16 clinical trials were completed. i.e. 43.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kocaeli University Medical Faculty" #1 sponsor was "Hoffmann-La Roche" with 22 trials, followed by "Kocaeli University" with 18 trials sponsored, "Janssen Research & Development, LLC" with 10 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored and "Pfizer" with 7 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kocaeli University Medical Faculty" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Düzen Laboratories Group" with 1 trials as a collaborator and "Easy-CRF" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Kocaeli University Medical Faculty" are "Multiple Sclerosis" (4 trials), "Ulcerative Colitis" (4 trials), "Difficult Intubation" (3 trials), "Relapsing Multiple Sclerosis" (3 trials) and "Acromegaly" (2 trials). Many other conditions were trialed in "Kocaeli University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Kocaeli University Medical Faculty" are "Drug" (54 trials), "Device" (14 trials), "Other" (8 trials), "Procedure" (7 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Ocrelizumab" (6 trials), "Airtraq" (4 trials), "Faricimab" (4 trials) and "Mirikizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Kocaeli University Medical Faculty" are 83 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kocaeli University Medical Faculty". undefined are not yet recruiting, 18 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Kocaeli University Medical Faculty, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Kocaeli University Medical Faculty, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 12 trials that are defined as “Not Applicable".